Axogen vs InMode
AXGN and INMD side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AXGN and INMD compare
Axogen grew revenue faster over the last twelve months (24.3% versus −6.2% for InMode).
Axogen scores higher on the StockData Score (11 against 6 for InMode), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AXGN | INMD |
|---|---|---|
| Size and price | ||
| Market cap | $3.3B | – |
| Share price | $55.93 | $13.27 |
| Change, 1 year | 132% | −9.2% |
| Change, 5 years | 473% | −85.0% |
| Beta (5Y) | 1.16 | 1.43 |
| Employees | 622 | 660 |
| StockData Score | ||
| Total score | 11 (better) | 6 |
| Valuation score | 0 | 0 |
| Growth score | 3 (better) | 0 |
| Performance score | 3 (better) | 1 |
| Health score | 5 | 5 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 12.5× | – |
| P/B | 6.7× | – |
| P/FCF | 152× | – |
| FCF yield | 0.66% | – |
| Fair value | $22.93 | – |
| Margin of safety | −144% | – |
| Growth | ||
| Revenue growth (TTM) | 24.3% (better) | −6.2% |
| Revenue growth, 5Y average | 14.9% (better) | 12.4% |
| EPS growth (TTM) | – | −36.4% |
| EPS growth, 5Y average | – | 9.9% |
| Profitability | ||
| Gross margin | 74.2% | 78.5% (better) |
| Operating margin | −5.2% | 23.0% (better) |
| Net margin | −12.0% | – |
| FCF margin | 8.3% | 22.7% (better) |
| Return on equity | −10.3% | – |
| Return on invested capital | −7.9% | 25.1% (better) |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Interest coverage | −5.7× | – |
| Current ratio | 12.02 (better) | 9.88 |
| Altman Z-score | 37.41 | – |
| Piotroski F-score | 5 | – |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | – |
| Ownership | ||
| Held by institutions | 90.4% | 49.5% |
| Held by insiders | 7.6% | 12.0% |
| Insider net buying, 12 months | −$17.1M | – |
| Short interest, % of float | 12.7% | 4.1% |
Go deeper
- AXGN stock overview
- AXGN income statement
- AXGN valuation and score
- INMD stock overview
- INMD income statement
- INMD valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.